DHFR and uterine cervix carcinoma in situ: Similarly, we confirmed the increased expression of DHFR and MRFAP1 in the validation panel including in nine of ten CIN I/II cases and six of seven CIN III cases and the overall trend of increase for this gene was statistically significant (p < .05).